Cannabis Khiron signs deal with Bogota’s largest public health insurance for medical cannabis coverage Only patients diagnosed with chronic pain, mental health, neurological conditions and epilepsy will be able to get coverage Natalia Buendia CalvilloJanuary 9, 2023
Cannabis Colombia includes medical cannabis in mandatory insurance coverage The government also revalidated medical conditions where medical practitioners have found cannabis to be effective Natalia Buendia CalvilloJanuary 5, 2023
Business Khiron launches new pot products in Europe The products will be distributed via the company's subsidiary Pharmadrug Production GmbH Natalia Buendia CalvilloSeptember 1, 2022
Business Khiron drops revenue by 4% to $4.5M in Q2 Khiron says it has developed a proven clinic business model with highly profitable medical cannabis sales in Colombia, the United Kingdom, Peru, Brazil and... Natalia Buendia CalvilloAugust 29, 2022
Business Khiron opens its first Zerenia Clinic in Brazil The Rio de Janeiro clinic has a capacity of 23,000 patient consultations per year Natalia Buendia CalvilloAugust 9, 2022
Business Khiron to acquire EU-GMP-certified German pharmaceuticals manufacturer The transaction is set to close on or before the end of July Natalia Buendia CalvilloMay 31, 2022
Business Khiron ups revenue by 60% to $12.8 million year-over-year The company currently has 13 subsidiaries in 10 different countries Natalia Buendia CalvilloMay 3, 2022
Business 92% of patients report improvements in chronic pain after using cannabis oil: Khiron study The study also found that seven out of ten patients did not suffer from adverse effects Natalia Buendia CalvilloApril 5, 2022
Business Khiron ups Q3 revenue 26% Growth was driven by medical cannabis clinic operations in Colombia and Germany, company says Natalia Buendia CalvilloNovember 22, 2021
Business Khiron opens its first medical cannabis clinic in Europe The company says it will use data from its clinics in Colombia and Peru to help treat patients in the UK Natalia Buendia CalvilloNovember 3, 2021